<DOC>
	<DOCNO>NCT01003405</DOCNO>
	<brief_summary>To investigate long-term safety , efficacy pharmacokinetics KUC-7483 patient overactive bladder .</brief_summary>
	<brief_title>Long-term Safety Efficacy KUC-7483 Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>p-Hydroxyamphetamine</mesh_term>
	<criteria>Patients successfully complete Phase III doubleblind study . Patients serious adverse event clinically significant adverse event Phase III doubleblind study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Overactive bladder</keyword>
	<keyword>Frequency</keyword>
	<keyword>Micturition</keyword>
	<keyword>Urgency</keyword>
	<keyword>Urge urinary incontinence</keyword>
	<keyword>OAB</keyword>
</DOC>